Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies
Lucero Rodriguez Rodriguez, Jonah Hall, Erwing Fabian Cardozo Ojeda, Rebecca M. Lynch, A PERELSON, Joshua Tisdell Schiffer, Daniel B. Reeves
The paper models in vivo functions of five anti-HIV bnAbs using clinical trial data to quantify neutralization, Fc-mediated killing, and resistance.
bioRxiv · Jun 16, 2026 · PreprintImmunology